Molecular epidemiology of SARS‐CoV‐2 in Mongolia, first experience with nanopore sequencing in lower‐ and middle‐income countries setting
Immunity, Inflammation and Disease · 2023
DOI: 10.1002/iid3.1095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2023. Verfasst von Munkhtuya Erendereg und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Infection Prevention Control, School of Biomedicine, Mongolian National University of Medical Sciences, Ulaanbaatar, M…. Hauptthemen laut MEDLINE: Nanopore Sequencing, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mongolian Foundation for Science and Technology, Ministry of Health, Government of Mongolia.
Abstract (Originalsprache)
Background
Coronavirus disease (COVID‐19) has had a significant impact globally, and extensive genomic research has been conducted on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) lineage patterns and its variants. Mongolia's effective response resulted in low prevalence until vaccinations became available. However, due to the lack of systematically collected data and absence of whole genome sequencing capabilities, we conducted a two‐stepped, nationally representative molecular epidemiologic study of SARS‐CoV‐2 in Mongolia for 2020 and 2021.
Methods
We used retrospective analysis of stored biological samples from November 2020 to October 2021 and a variant‐specific real‐time reverse transcription polymerase chain reaction (RT‐PCR) test to detect SARS‐CoV‐2 variants, followed by whole genome sequencing by Nanopore technology. Samples were retrieved from different sites and stored at −70°C deep freezer, and tests were performed on samples with cycle threshold
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Infection Prevention Control, School of Biomedicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
- Intermed Hospital, Ulaanbaatar, Mongolia.
- Institute of Biomedical Sciences, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
- National Center for Zoonotic Disease, Ulaanbaatar, Mongolia.
- National Center for Public Health, Ulaanbaatar, Mongolia.
- Division for Science and Technology, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
ORCID-Profile: Suvd Tumurbaatar, Otgonjargal Byambaa, Gerelmaa Enebish, Natsagdorj Burged, Badmaarag Munkhjin, Jargaltulga Ulziijargal, Anuujin Gantumur, Oyunbaatar Altanbayar, Ochbadrakh Batjargal, Khosbayar Tulgaa, Tsogbadrakh Nyamdorj, Naranzul Tsedenbal, Baigalmaa Jantsansengee, Battur Lkhagvaa, Bilegtsaikhan Tsolmon, Oyunsuren Enebish, Erdembileg Tsevegmid, Ryenchindorj Erkhembayar, Battogtokh Chimeddorj
Förderung
- Mongolian Foundation for Science and Technology
- Ministry of Health, Government of Mongolia
Zitieren
APA
Erendereg, M., Tumurbaatar, S., Byambaa, O., Enebish, G., Burged, N., Khurelsukh, T., Baatar, N. E., Munkhjin, B., Ulziijargal, J., Gantumur, A., Altanbayar, O., Batjargal, O., Altangerel, D., Tulgaa, K., Ganbold, S., Tundev, O., Jigjidsuren, S., Nyamdorj, T., Tsedenbal, N., …, & Chimeddorj, B. (2023). Molecular epidemiology of SARS‐CoV‐2 in Mongolia, first experience with nanopore sequencing in lower‐ and middle‐income countries setting. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1095
Vancouver
Erendereg M, Tumurbaatar S, Byambaa O, Enebish G, Burged N, Khurelsukh T, et al. Molecular epidemiology of SARS‐CoV‐2 in Mongolia, first experience with nanopore sequencing in lower‐ and middle‐income countries setting. Immunity, Inflammation and Disease. 2023. doi:10.1002/iid3.1095
BibTeX
@article{Erendereg2023,
author = {Erendereg, Munkhtuya and Tumurbaatar, Suvd and Byambaa, Otgonjargal and Enebish, Gerelmaa and Burged, Natsagdorj and Khurelsukh, Tungalag and Baatar, Nomin-Erdene and Munkhjin, Badmaarag and Ulziijargal, Jargaltulga and Gantumur, Anuujin and Altanbayar, Oyunbaatar and Batjargal, Ochbadrakh and Altangerel, Delgermurun and Tulgaa, Khosbayar and Ganbold, Sarangua and Tundev, Odgerel and Jigjidsuren, Sarantsetseg and Nyamdorj, Tsogbadrakh and Tsedenbal, Naranzul and Batmunkh, Bumdelger and Jantsansengee, Baigalmaa and Lkhagvaa, Battur and Tsolmon, Bilegtsaikhan and Enebish, Oyunsuren and Tsevegmid, Erdembileg and Sereejav, Enkhbold and Nyamdavaa, Khurelbaatar and Erkhembayar, Ryenchindorj and Chimeddorj, Battogtokh},
title = {Molecular epidemiology of SARS‐CoV‐2 in Mongolia, first experience with nanopore sequencing in lower‐ and middle‐income countries setting},
journal = {Immunity, Inflammation and Disease},
year = {2023},
doi = {10.1002/iid3.1095}
}
EUVIMED